The Cigna Group
CI
$346.72
$2.790.81%
| Weiss Ratings | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Reward Grade | B | |||
| Rating Factors | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Fair | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.31 | |||
| Price History | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.08% | |||
| 30-Day Total Return | -2.03% | |||
| 60-Day Total Return | 2.07% | |||
| 90-Day Total Return | 0.61% | |||
| Year to Date Total Return | 11.95% | |||
| 1-Year Total Return | 20.03% | |||
| 2-Year Total Return | 22.08% | |||
| 3-Year Total Return | 73.73% | |||
| 5-Year Total Return | 140.58% | |||
| 52-Week High % Change | -7.25% | |||
| 52-Week Low % Change | 35.43% | |||
| Price | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $370.83 | |||
| 52-Week Low Price | $253.95 | |||
| 52-Week Low Price (Date) | Dec 08, 2023 | |||
| 52-Week High Price (Date) | Sep 16, 2024 | |||
| Valuation | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 96.15B | |||
| Enterprise Value | 122.16B | |||
| Price/Earnings (TTM) | 27.06 | |||
| Earnings Per Share (TTM) | 12.71 | |||
| Earnings Per Share Growth | -42.31% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.45 | |||
| Price/Book (Q) | 2.33 | |||
| Enterprise Value/Revenue (TTM) | 0.57 | |||
| Price | $346.72 | |||
| Enterprise Value/EBITDA (TTM) | 11.52 | |||
| Enterprise Value/EBIT | 16.09 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 284.05M | |||
| Dividend Yield | 1.58% | |||
| Div. Per Share (Most Recent) | $1.40 | |||
| Dividend Per Share (TTM) | $5.43 | |||
| Payout Ratio (TTM) | 40.80% | |||
| Dividend Per Share (Most Recent) | $1.40 | |||
| Company Info | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 860 226 6000 | |||
| Address | 900 Cottage Grove Road Bloomfield, CT 06002 | |||
| Website | www.cigna.com | |||
| Country | United States | |||
| Year Founded | 1792 | |||
| Profitability | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 3.51% | |||
| Profit Margin | 1.71% | |||
| Management Effectiveness | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.11% | |||
| Return on Equity | 9.13% | |||
| Income Statement | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 204.72B | |||
| Total Revenue (TTM) | 216.01B | |||
| Revenue Per Share | $760.45 | |||
| Gross Profit (TTM) | 24.02B | |||
| EBITDA (TTM) | 10.60B | |||
| EBIT (TTM) | 7.59B | |||
| Net Income (TTM) | 3.71B | |||
| Net Income Avl. to Common (TTM) | 3.71B | |||
| Total Revenue Growth (Q YOY) | 24.40% | |||
| Earnings Growth (Q YOY) | 7.88% | |||
| EPS Diluted (TTM) | 12.71 | |||
| EPS Diluted Growth (Q YOY) | 10.77% | |||
| Balance Sheet | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 7.67B | |||
| Cash Per Share (Q) | $26.98 | |||
| Total Current Assets (Q) | 46.02B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 41.53B | |||
| Current Ratio (Q) | 0.831 | |||
| Book Value Per Share (Q) | $147.88 | |||
| Total Assets (Q) | 155.45B | |||
| Total Current Liabilities (Q) | 55.37B | |||
| Total Debt (Q) | 32.61B | |||
| Total Liabilities (Q) | 113.92B | |||
| Total Common Equity (Q) | 41.33B | |||
| Cash Flow | CI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.91B | |||
| Cash from Financing (TTM) | -8.66B | |||
| Net Change in Cash (TTM) | -3.27B | |||
| Levered Free Cash Flow (TTM) | 1.70B | |||
| Cash from Operations (TTM) | 9.40B | |||
